The Lung Research Center

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Idiopathic pulmonary fibrosis3 trials
• COPD1 trial

Phase

• Phase 22 trials
• Phase 32 trials

Status

• Completed2 trials
• Active, not recruiting1 trial
• Terminated1 trial

Lead sponsor

• Hoffmann-La Roche1 trial
• Pliant Therapeutics, Inc.1 trial
• Tvardi Therapeutics, Incorporated1 trial
• United Therapeutics1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)

  NCT05878769· Phase 3· Hoffmann-La Roche· Source

Closed trials

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Pliant Therapeutics, Inc.· Source

• Completed

  Study of TTI-101 in Participants With Idiopathic Pulmonary Fibrosis

  NCT05671835· Phase 2· Tvardi Therapeutics, Incorporated· Source

• Completed

  Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis

  NCT04708782· Phase 3· United Therapeutics· Source